XML 101 R71.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-based payments transactions (Tables)
 12 Months Ended
Mar. 31, 2024
Share-Based Payments Transactions [Abstract]  
Disclosure of Number and Reconciliation of Outstanding Share Options
On October 23, 2020, a total of 8 million share options were granted to employees of the Group with four tranches of options vesting on four respective vesting dates (“SOP 2020”), whereas within each of the four tranches, there are further four tranches of options with four different exercise prices, as below:
Vesting dateTotal
Share options granted (thousands)05/03/202205/09/202205/09/202305/09/2024
US$8.50971 324 647 647 2,589 
US$10.50822 274 548 548 2,192 
US$12.50673 224 448 448 1,793 
US$14.50523 175 349 349 1,396 
Total2,989 997 1,992 1,992 7,970 
The strike price of the existing SOP 2020 grant has been adjusted as set forth below, while all the other terms of the SOP 2020 remained unaffected.
SOP 2020 CEO MOD - Number of shares (thousand)
Original Option Strike PriceNew Option Strike PriceVesting dateTotal
15/02/202215/08/202215/08/202315/08/2024
US$8.50 US$6.42 335 112 223 223 893 
US$10.50 US$8.42 284 95 189 189 757 
US$12.50 US$10.42 232 77 155 155 619 
US$14.50 US$12.42 180 60 120 120 480 
Total1,031 344 687 687 2,749 
SOP 2020 MOD - Number of shares (thousand)
Option Strike PriceVesting dateTotal
15/02/202215/08/202215/08/202315/08/2025
US$6.00 716 225 450 450 1,842 
US$7.50 597 188 375 375 1,535 
US$9.00 485 152 304 304 1,245 
US$10.50 375 118 235 235 962 
Total2,173 683 1,365 1,363 5,584 
The following table shows the SOPs granted and outstanding at the beginning and end of the reporting periods:
For the financial year ended March 31
202420232022
Average exercise price per share option (USD)Number of options (thousands)Average exercise price per share option (USD)Number of options (thousands)Average exercise price per share option (USD)Number of options (thousands)
As of April 111.42 7,952 11.42 7,980 11.40 8,457 
Granted during the period— — — — — — 
Replaced during the period10.20 (1,680)— — — — 
Forfeited during the period10.90 (28)11.50 (28)10.98 (477)
As of March 318.00 6,244 11.42 7,952 11.42 7,980 
Vested and exercisable of March 318.00 4,657 11.42 4,072 11.01 2,925 
Number of shares (million)For the financial year ended March 31
20242023
As of April 1452 — 
Granted during the year— 452 
Vested during the year— — 
Forfeited during the year(452)— 
As of March 31— 452 
Weighted average fair value (EUR)— 0.13 
Weighted average remaining contractual life of options outstanding at the end of the period (years)02.5
Disclosure of Indirect Measurement of Fair Value of Share Options Granted
SOP 2019 MODBefore modificationAfter modification
Vesting date25/6/202225/6/202425/6/202225/6/2025
Share price at mod. date (USD)4.644.644.644.64
Exercise price (USD)10.5910.597.507.50
Expected volatility29.00%30.00%31.00%31.00%
Risk free interest rate4.70%4.70%4.60%4.40%
Fair value at mod. date (USD)0.020.030.290.42
SOP 2020 MODBefore modification
Vesting date15/2/202215/8/202215/8/202315/8/2024
Share price at mod. date (USD)4.644.644.644.64
Expected volatility28.00%28.00%28.00%29.00%
Risk free interest rate4.90%4.90%4.90%4.80%
Exercise price (USD)8.508.508.508.50
Fair value at mod. date (USD)0.040.040.040.07
Exercise price (USD)10.5010.5010.5010.50
Fair value at mod. date (USD)0.010.010.010.02
Exercise price (USD)12.5012.5012.5012.50
Fair value at mod. date (USD)0.000.000.000.00
Exercise price (USD)14.5014.5014.5014.50
Fair value at mod. date (USD)0.000.000.000.00
Exercise price (USD)6.426.426.426.42
Fair value at mod. date (USD)0.210.210.210.27
Exercise price (USD)8.428.428.428.42
Fair value at mod. date (USD)0.050.050.050.07
Exercise price (USD)10.4210.4210.4210.42
Fair value at mod. date (USD)0.010.010.010.02
Exercise price (USD)12.4212.4212.4212.42
Fair value at mod. date (USD)0.000.000.000.00

SOP 2020 MODAfter modification
Vesting date15/2/202215/8/202215/8/202315/8/2025
Share price at mod. date (USD)4.644.644.644.64
Expected volatility32.00%32.00%32.00%31.00%
Risk free interest rate4.50%4.50%4.50%4.40%
Exercise price (USD)6.006.006.006.00
Fair value at mod. date (USD)0.630.630.630.77
Exercise price (USD)7.507.507.507.50
Fair value at mod. date (USD)0.330.330.330.45
Exercise price (USD)9.009.009.009.00
Fair value at mod. date (USD)0.180.180.180.27
Exercise price (USD)10.5010.5010.5010.50
Fair value at mod. date (USD)0.100.100.100.16
Disclosure of Range of Exercise Prices of Outstanding Share Options
Share options outstanding at the end of the year have the following expiry dates and exercise prices:
Share options outstanding (thousands)For the financial year ended March 31
Grant / modification dateExpiry dateExercise price (USD)202420232022
June 25, 2019June 25, 202710.59 38 461 461 
March 4, 2024June 25, 20287.50 293 — — 
October 23, 2020November 12, 20268.50 107 1,540 2,443 
October 23, 2020November 12, 202610.50 90 1,304 2,068 
October 23, 2020November 12, 202612.50 74 1,067 1,692 
October 23, 2020November 12, 202614.50 58 830 1,316 
October 23, 2020November 12, 20266.42 — 894 — 
October 23, 2020November 12, 20268.42 — 756 — 
October 23, 2020November 12, 202610.42 — 619 — 
October 23, 2020November 12, 202612.42 — 481 — 
March 4, 2024November 12, 20286.00 1,841 — — 
March 4, 2024November 12, 20287.50 1,535 — — 
March 4, 2024November 12, 20289.00 1,245 — — 
March 4, 2024November 12, 202810.50 963 — — 
Total6,244 7,952 7,980 
Weighted average remaining contractual life of options outstanding at the end of the period4.763.153.15
Disclosure of Indirect Measurement of Fair Value of Restricted Shares Granted The model inputs were the share price at grant date and the risk free interest rate as stipulated in the table below. No dividend payments were considered in the fair value.
RSA 2023RSA 2023 CEO
Grant date1/9/20231/9/20231/9/20231/9/202325/8/202325/8/2023
Vesting date29/8/202429/8/202529/8/202629/8/202729/8/202429/8/2025
Share price at grant date (USD)5.63 5.63 5.63 5.63 5.76 5.76 
Expected volatility27.0%44.0%55.0%72.0%27.0%44.0%
Risk free interest rate5.6%5.1%4.8%4.6%5.6%5.1%
Fair value per share (USD)4.214.083.953.824.304.18
Disclosure of Number and Reconciliation of Outstanding Restricted Shares
The following table shows the RSAs granted and outstanding at the beginning and end of each reporting period:
Number of shares (thousands)For the financial year ended March 31
202420232022
As of April 12,006 1,675 475 
Granted during the year1,064 962 1,426 
Vested during the year(970)(539)(92)
Forfeited during the year(149)(92)(134)
As of March 311,951 2,006 1,675 
Weighted average fair value (USD)4.26 5.186.62